A HIGHLY POTENT, ORALLY-ACTIVE IMIDAZO[4,5-B]PYRIDINE BIPHENYLACYLSULFONAMIDE (MK-996-L-159,282) - A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST

被引:58
|
作者
CHAKRAVARTY, PK
NAYLOR, EM
CHEN, A
CHANG, RSL
CHEN, TB
FAUST, KA
LOTTI, VJ
KIVLIGHN, SD
GABLE, RA
ZINGARO, GJ
SCHORN, TW
SCHAFFER, LW
BROTEN, TP
SIEGL, PKS
PATCHETT, AA
GREENLEE, WJ
机构
[1] MERCK SHARP & DOHME LTD,DEPT NEW LEAD PHARMACOL,W POINT,PA 19486
[2] MERCK SHARP & DOHME LTD,DEPT PHARMACOL,W POINT,PA 19486
关键词
D O I
10.1021/jm00050a002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:4068 / 4072
页数:5
相关论文
共 22 条
  • [21] Pharmacological characterization of MK-0974 [N-[(3R, 6S)-6(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b] pyridin-1-yl)piperidine-1-carboxamide], a potent and orally Active calcitonin gene-related peptide receptor antagonist for the treatment of migraine
    Salvatore, Christopher A.
    Hershey, James C.
    Corcoran, Halea A.
    Fay, John F.
    Johnston, Victor K.
    Moore, Eric L.
    Mosser, Scott D.
    Burgey, Christopher S.
    Paone, Daniel V.
    Shaw, Anthony W.
    Graham, Samuel L.
    Vacca, Joseph P.
    Williams, Theresa M.
    Koblan, Kenneth S.
    Kane, Stefanie A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (02): : 416 - 421
  • [22] Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine:: Discovery of N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide (MK-0974)
    Paone, Daniel V.
    Shaw, Anthony W.
    Nguyen, Diem N.
    Burgey, Christopher S.
    Deng, James Z.
    Kane, Stefanie A.
    Koblan, Kenneth S.
    Salvatore, Christopher A.
    Mosser, Scott D.
    Johnston, Victor K.
    Wong, Bradley K.
    Miller-Stein, Cynthia M.
    Hershey, James C.
    Graham, Samuel L.
    Vacca, Joseph P.
    Williams, Theresa M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (23) : 5564 - 5567